Xingnan Zheng

Xingnan Zheng

Auto-generated profile, based on publicly available information

Xingnan Zheng

Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2018 in Science
Verified
Journal Article
Closed access
PDF file
JZJing Zhang
Jing Zhang
TWTao Wu
Tao Wu
JSJeremy Simon
Jeremy Simon
MTMamoru Takada
Mamoru Takada
RSRyoichi Saito
Ryoichi Saito
QZQING ZHANG
QING ZHANG
Mechanistic insights into kidney cancer: Many clear cell renal cell carcinomas (ccRCCs) have alterations to the gene encoding the von Hippel-Lindau protein (VHL). VHL is a ubiquitin ligase that degrades target proteins when they are prolyl-hydroxylated. Zhang et al. performed a genome-wide search for VHL target (see the Perspective by Sanchez and Simon). They identified ZHX2, a protein with structural motifs that indicate DNA binding. ZHX2 has been implicated in tumor suppression. Loss of ZHX2 inhibited signaling through the transcription factor NF-κB, and ZHX2 bound to many NF-κB target genes. Depletion of ZHX2 slowed growth of ccRCC cells in vitro and in a mouse model. Science , this issue p. 290 ; see also p. 226

27 May 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KHKai Hong
Kai Hong
LHLianxin Hu
Lianxin Hu
XLXijuan Liu
Xijuan Liu
JSJeremy M. Simon
Jeremy M. Simon
TPTravis S. Ptacek
Travis S. Ptacek
QZQING ZHANG
QING ZHANG
Clear cell renal cell carcinoma (ccRCC) is characterized by loss of tumor suppressor Von Hippel Lindau (VHL) function, which leads to accumulation of hypoxia inducible factor α (including HIF1α and HIF2α). HIF2α was previously reported to be one of the major oncogenic drivers in ccRCC, however, its therapeutic targets remain challenging. Here we performed a deubiquitinase (DUB) complementary DNA (cDNA) library binding screen and discovered that ubiquitin-specific peptidase 37 (USP37) is a DUB that binds HIF2α and promotes HIF2α deubiquitination. As a result, USP37 promotes HIF2α protein stability in an enzymatically dependent manner, and depletion of USP37 leads to HIF2α down-regulation in ccRCC. Functionally, USP37 depletion causes decreased cell proliferation measured by MTS, two-dimensional (2D) colony formation as well as three-dimensional (3D) anchorage- independent growth. USP37 is also essential for maintaining kidney tumorigenesis in an orthotopic xenograft model and its depletion leads to both decreased primary kidney tumorigenesis and spontaneous lung metastasis. Our results suggest that USP37 is a potential therapeutic target in ccRCC.

3 April 2023
Verified
Other
Open access
KHKan He
Kan He
XZXingnan Zheng
Xingnan Zheng
LZLin Zhang
Lin Zhang
JYJian Yu
Jian Yu
PDF - 480KB, Figure S1. Levels of AKT, p-ERK and ERK change following 17AAG treatment; Figure S2. PUMA but not Bim is required for 17AAG-induced apoptosis in HCT 116 cells; Figure S3. PUMA is required for apoptosis induced by other Hsp90 inhibitors; Figure S4. p21 induction suppresses 17AAG-induced apoptosis; Figure S5. p53-KO HCT 116 cells are resistant to apoptosis induced by other Hsp90 inhibitors; Figure S6. 17AAG induces XBP1 splicing but XBP1 siRNA did not affect PUMA induction by 17AAG.